Pleomorphism (cytology): Difference between revisions
Content deleted Content added
m Reverted edits by 45.244.32.231 (talk) (HG) (3.1.20) |
m alpha, move hat |
||
| Line 1: | Line 1: | ||
| ⚫ | |||
{{unreferenced|date=August 2012}} |
{{unreferenced|date=August 2012}} |
||
| ⚫ | |||
[[Image:Serous carcinoma 2a - cytology.jpg|right|thumb|200px|A [[micrograph]] showing cells with marked nuclear shape and size variation, a component of nuclear '''pleomorphism'''.]] |
[[Image:Serous carcinoma 2a - cytology.jpg|right|thumb|200px|A [[micrograph]] showing cells with marked nuclear shape and size variation, a component of nuclear '''pleomorphism'''.]] |
||
| Line 9: | Line 8: | ||
==See also== |
==See also== |
||
*[[ |
*[[Anaplasia]] |
||
*[[Cytopathology]] |
*[[Cytopathology]] |
||
*[[Giant cell carcinoma of the lung]] |
*[[Giant cell carcinoma of the lung]] |
||
*[[ |
*[[Nuclear atypia]] |
||
{{pathology-stub}} |
{{pathology-stub}} |
||
Revision as of 03:27, 11 May 2017
 |
Pleomorphism is a term used in histology and cytopathology to describe variability in the size, shape and staining of cells and/or their nuclei.
It is a feature characteristic of malignant neoplasms, and dysplasia. Certain benign cell types may have pleomorphism, e.g. neuroendocrine cells, Arias-Stella reaction.
See also
_histopatholgy.jpg){kind=small} | This article related to pathology is a stub. You can help Wikipedia by expanding it. |